Position in NTRA
as of Jun 30, 2026
· filed Jul 20, 2026
Position Value
$1,829,301
New position
Shares Held
6,739
first reported quarter
Ownership
0.005%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#376
of 844 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026GATEWAY INVESTMENT ADVISERS LLC holds $44,798,846 across 16 Diagnostics & Research names. NTRA ranks #6 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ICLR |
Icon PLC
|
53,557 | $9,303,386 | |
| 2 | ILMN |
Illumina, Inc.
|
51,349 | $9,028,694 | |
| 3 | MEDP |
Medpace Holdings, Inc.
|
15,145 | $8,020,640 | |
| 4 | IDXX |
Idexx Laboratories Inc /De
|
8,920 | $4,695,844 | |
| 5 | TMO |
Thermo Fisher Scientific Inc.
|
7,931 | $3,976,286 | |
| 6 | NTRA |
Natera, Inc.
This page
|
6,739 | $1,829,301 | |
| 7 | QGEN |
Qiagen N.V.
|
43,833 | $1,713,870 | |
| 8 | A |
Agilent Technologies, Inc.
|
12,355 | $1,641,114 |
All Filings in NTRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,829,301 | 6,739 | Shares | Sole | 2026-07-20 | |
| No filing history on record for this holder in this stock. | ||||||